TCG Crossover Fund & Chen Yu Amend KalVista Stake

TL;DR

TCG Crossover & Chen Yu updated their KalVista stake filing on 4/1/24.

AI Summary

TCG Crossover Fund I, L.P. and Chen Yu have filed an amendment (Amendment No. 2) to their Schedule 13D regarding KalVista Pharmaceuticals, Inc. The filing, dated April 1, 2024, indicates a change in beneficial ownership. The specific details of the change in ownership percentage or holdings are not fully detailed in this excerpt, but it represents an update to their previous filing.

Why It Matters

This filing signals a potential shift in major shareholder influence or strategy for KalVista Pharmaceuticals, which could impact its stock price and future corporate actions.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate events or shifts in control, introducing uncertainty.

Key Players & Entities

• TCG Crossover Fund I, L.P. (company) — Filing entity
• Chen Yu (person) — Filing entity
• KalVista Pharmaceuticals, Inc. (company) — Subject company
• 20240401 (date) — Filing date

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• d820787dsc13da.htm (SC 13D/A) — 64KB
• 0001193125-24-083385.txt ( ) — 66KB

From the Filing

SC 13D/A 1 d820787dsc13da.htm SC 13D/A SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* KALVISTA PHARMACEUTICALS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 483497 10 3 (CUSIP Number) Craig Skaling Chief Financial Officer TCG Crossover GP I, LLC 705 High St. Palo Alto, CA 94301 (650)-924-9424 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 28, 2024 (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 483497103 13D 1. Name of Reporting Persons TCG Crossover GP I, LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Source of Funds (See Instructions) AF 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) 6. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 0 8. Shared Voting Power 1,345,826 (1) 9. Sole Dispositive Power 0 10. Shared Dispositive Power 1,345,826 (1) 11. Aggregate Amount Beneficially Owned by Each Reporting Person 1,345,826 (1) 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) 13. Percent of Class Represented by Amount in Row (11) 3.2% (2) 14. Type of Reporting Person (See Instructions) OO (1) These securities are held by TCG Crossover I (as defined in Item 2(a) below) and consist of (i) 1,163,356 shares of Common Stock (as defined in Item 1(a) below) and (ii) 182,470 shares of Common Stock underlying pre-funded warrants which are exercisable within 60 days of the date hereof. TCG Crossover GP I (as defined in Item 2(a) below) is the general partner of TCG Crossover I and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP I and may be deemed to share voting, investment and dispositive power with respect to these securities. (2) Based on 42,370,766 shares of the Issuers Common Stock, which consists of (i) 42,188,296 shares of the Issuers Common Stock outstanding as of March 8, 2024, as reported in the Issuers Quarterly Report on Form 10-Q and filed with the Securities and Exchange Commission (the Commission) on March 11, 2024 (the Form 10-Q), plus (ii) 182,470 shares of the Issuers Common Stock issuable upon exercise of the pre-funded warrants held by TCG Crossover I. CUSIP No. 483497103 13D 1. Name of Reporting Persons TCG Crossover Fund I, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Source of Funds (See Instructions) WC 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) 6. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 0 8. Shared Voting Power 1,345,826 (1) 9. Sole Dispositive Power 0 10. Shared Dispositive Power 1,345,826 (1) 11. Aggregate Amount Beneficially Owned by Each Reporting Person 1,345,826 (1) 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) 13. Percent of Class Represented by Amount in Row (11) 3.2% (2) 14. Type of Reporting Person (See Instructions) PN (1) These securities are held by TCG Crossover I and consist of (i) 1,163,356 shares of Common Stock and (ii) 182,470 shares of Common Stock underlying pre-funded warrants which are exercisable within 60 days of the date hereof. TCG Crossover GP I is the general partner of TCG Crossover I and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP I and may be deemed to share voting, investment and dispositive power with respect to these securities. (2) Based on 42,370,766 shares of the Issuers Common Stock

View Full Filing

View this SC 13D/A filing on SEC EDGAR